Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Pierre Daram, Ph.D.
Global Antibiotic R&D Partnership (GARDP), Switzerland
Poster(s):
(P-1251) Pharmacometric Analyses to Support Dose Selection of Zoliflodacin, a First-in-Class Oral Antibiotic Being Developed for the Treatment of Uncomplicated Gonorrhea
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT